To hear about similar clinical trials, please enter your email below
Trial Title:
Definition of Surgical Technique of Lymphadenectomy and Complete Mesocolon Excision for Radical Right Colectomy: a Delphi Consensus
NCT ID:
NCT05544474
Condition:
Colon Cancer
Conditions: Official terms:
Colonic Neoplasms
Study type:
Observational
Overall status:
Enrolling by invitation
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Delphi questionnaire
Description:
An invitation email, including a link to the survey, will be sent to the panel of experts
in the field of radical right colectomy. The Delphi questionnaire will be administered
via www.surveymonkey.com.
In the first survey, panel members will agree on surgical steps, definition of surgical
steps and nomenclature for radical right colectomy In subsequent surveys, panel expert
will agree on a common definition, nomenclature and reporting for right colectomy.
Multiple rounds will be conducted until consensus is reached. After each round, the study
team will calculate the agreement and distribution of responses. Likert responses will be
dichotomized with positive values indicating agreement and neutral or negative values
indicating disagreement.
For the questions that do not reach a consensus of more than 70% in the first round or
need further explanation, additional rounds of the survey may be performed.
Arm group label:
Expert surgeon on radical right colectomy
Summary:
A Delphi consensus to define surgical steps of lymphadenectomy and complete mesocolic
excision for radical right colectomy
Criteria for eligibility:
Study pop:
Expert surgeon on radical right colectomy
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Experts in the fields of radical right colectomy
Exclusion Criteria:
- Panelists who were not able to commit to all rounds of the modified Delphi process
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
University of Rome Tor Vergata
Address:
City:
Rome
Zip:
00133
Country:
Italy
Start date:
November 28, 2023
Completion date:
August 15, 2024
Lead sponsor:
Agency:
University of Rome Tor Vergata
Agency class:
Other
Source:
University of Rome Tor Vergata
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05544474
https://doi.org/10.1007/s00464-022-09548-5
